1Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmune Rev, 2006, 5:465-470.
2Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable. J Clin Immunol, 2007, 27:308-316.
3Bematowska E. The primary immunodeficiency network on European and national levels where are we now? Centr Eur J Immunol, 2005, 30: 75-77.
4Salzer U, Grimbacher B. Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation? Curr Opin Rheumatol, 2006, 18:377-382.
5Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol, 2006, 117:740-746.
6Baryry J, Hemline O, Webster DA, et al. Common variable immunodeficiency : the immune system in chaos. Trends Mol Med, 2005, 11 : 370-376.
7Fernandez-Castro M, Mellor-Pita S, Citores MJ, et al. Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum, 2007, 36:238-245.
8Sordet C, Cantagrel A, Schaeverbeke T, et al. Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine, 2005, 72:503-514.
9Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmune Rev, 2006,5 : 156-159.
10Ballow M. Clinical and investigational considerations for the use of IVIG therapy. Am J Health Syst Pharm, 2005,62( 16 Suppl 3 ) : S12-18.
